SUMMARY
The final number of antihypertensive drugs used in the long-term treatment of a given patient is not always predictable at the start of therapy.
By reviewing clinical records, we retrospectively examined the relationship between pretreatment blood pressure and the final number of drugs administered in 282 patients with mild to moderate hypertension who had been treated for 5 years or more (average 9.7 years).
After years of treatment approximately one third and one half of 137 patients with a pretreatment diastolic blood pressure of between 90 and 104 mmHg were well controlled with combined therapy and monotherapy, respectively.
The drugs had been withdrawn in the remaining 17% for 12 months or more. Lower pretreatment systolic blood pressure and lower pretreatment QRS voltage were signs favorable for withdrawal of the drugs.
Combined therapy was required in more than half the patients with higher pretreatment diastolic blood pressure. 
RESULTS
Pretreatment blood pressure and final therapy: Table I shows the pretreatment and final blood pressures in the 2 groups classified by pretreatment diastolic blood pressure. After an average of 9.7 years of treatment, the final blood pressure reached similar levels which lay within a narrow range from 143 to 145mmHg systolic and from 85 to 89 mmHg diastolic in each group, despite the great differences in their pretreatment blood pressures. Table II shows the pretreatment and final blood pressures in the 3 groups classified by the modes of treatment in the final 12 months period. The pretreatment blood pressure was highest for the combined therapy group, second highest for the monotherapy group and lowest for the drug withdrawal group, but there were no significant differences in Table III shows the relationship between the pretreatment levels of diastolic blood pressure and the modes of treatment in the final 12 months period. In the group with a higher pretreatment diastolic blood pressure, more combined therapy and less monotherapy was required. Combined therapy was used in 42 (30.7%) of 137 patients with a pretreatment diastolic blood pressure of 90-104mmHg, and in 80 (55.2%) of 145 patients with a corresponding pressure of 105-119mmHg. The difference between the 2 groups was statistically significant (p<0.01). Seventy two (52.6%) of the 137 patients with a pretreatment diastolic blood pressure of 90-104mmHg were treated with monotherapy, while 55 (37.9%) of the 145 patients with a corresponding pressure of 105-119mmHg were treated with monotherapy in the final 12 months period. The difference between the 2 groups was also significant (p< 0.05). Diuretics were used as the sole antihypertensive drug in 91 (71.7%) of 127 patients who had been treated with monotherapy. The diuretics used in these patients were hydrochlorothiazide 25 to 50mg or trichlormethiazide 2 to 4mg per day.
Withdrawal of drug therapy: Blood pressure had been well controlled during the final 12 months despite discontinuation of antihypertensive drugs in 33 (11.7%) of the total 282 patients. In these 33 patients the average duration of antihypertensive drug treatment was 5.5 years and the average observation period after discontinuation of drugs was 4.5 years. The frequency of drug withdrawal was significantly lower in patients with higher pretreatment diastolic blood pressure than in those with a lower one. The withdrawal of antihypertensive drugs was observed in 10 (6.5%) of 145 patients with a pretreatment diastolic blood pressure of 105-119mmHg, compared with in 23 (16.8%) of 137 patients with a corresponding blood pressure of 90-104mmHg (p<0.01). The withdrawal of drugs was never observed in any of the 24 patients with a pretreatment diastolic blood pressure of 115-119mmHg.
The conditions under which treatment with antihypertensive drugs was stopped, and the motives for doing so, were examined in the 33 drug with- 
DISCUSSION
This retrospective review of clinical records revealed a close relationship between pretreatment blood pressure and final modes of treatment in patients with mild to moderate hypertension.
An average of 9.7 years after the start of antihypertensive drug treatment, one third, one half and the remaining 17% of patients with a pretreatment diastolic blood pressure of 90-104mmHg were well controlled with combined therapy, monotherapy and following drug withdrawal, respectively.
Combined therapy was required more often and monotherapy was required less in patients with higher pretreatment diastolic blood pressure.
The results presented here reflect the actual state of hypertension treatment in Japan and demonstrate the capability of monotherapy and the possibility of withdrawing antihypertensive drugs in the long-term treatment of hypertension.
The withdrawal of antihypertensive drugs was first described by Perry and Schroeder1) and 10 years later reconfirmed by the same group.2) In their latter study, prolonged remission was observed in 16 (5.1%) of 316 patients after discontinuation of drugs. However, their studies drew little attention, because the patients were treated with unusually high doses of hexamethonium and hydralazine.
Recently, increasing attention has been paid to withdrawal of antihypertensive drugs. Several groups7)-12) have conducted prospective studies of the effects of withdrawing antihypertensive drugs on blood pressure in patients with well-controlled mild hypertension and have confirmed that in some patients drugs can be successfully withdrawn, although the rates of withdrawal have ranged widely from 8 to 74%. Such studies do not always reflect the real state of hypertension treatment in a general population, since antihypertensive drugs are intentionally withdrawn in selected patients.
In a recent report by Alderman et al,11) antihypertensive drugs were successfully withdrawn in 44 (28%) of 157 patients with well-controlled hypertension who had been drawn from a screened population of union members. In the present retrospective study, the rate of withdrawal was 17% for patients whose pretreatment diastolic blood pressure had been between 90 and 104mmHg. If the drugs had been intentionally withdrawn, the rate of withdrawal might have reached a level similar to that reported by Alderman et al.
In mild hypertension, spontaneous remission appears to be more common than expected. In the Australian Trial14) diastolic blood pressure fell to less than 95mmHg without antihypertensive drugs over a 3 year period in half of the patients with mild hypertension.
In the present study, we also cannot exclude the possibility that antihypertensive drugs might not have been originally necessary for patients from whom the drugs were later withdrawn, because the pretreatment period was too short to allow observation of spontaneous remission.
It would be useful from a practical point of view to distinguish characteristics favorable for withdrawal of antihypertensive drugs. In their study on the effects of diuretic withdrawal in 62 well-controlled patients with mild hypertension, Maland et al8) found that patients with reversal of hypertension were slightly older and had slightly higher pretreatment blood pressure, although none of these differences was statistically significant. The present study showed that a lower pretreatment systolic blood pressure and lower pretreatment QRS voltage were signs favorable for withdrawal of antihypertensive drugs in patients with mild hypertension. Recently, Langford et al10) demonstrated that weight loss and sodium restriction slowed the reappearance of hypertension after withdrawal of antihypertensive drugs. The effects of dietary intervention and changes of life style on the withdrawal of antihypertensive drugs will require further investigation.
